Steven Cohen Pro Qr Therapeutics N.V. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.9 - $8.39 $414,900 - $3.87 Million	-461,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.58 - $8.44 $20,398 - $26,164	3,100 Added 0.68%	461,000 $3.69 Million
Q3 2021 Nov 15, 2021	BUY	$5.16 - $8.47 $2.36 Million - $3.88 Million	457,900 New	457,900 $3.83 Million
Q2 2021 Aug 16, 2021	SELL	$5.75 - $7.59 $8.75 Million - $11.6 Million	-1,521,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.14 - $9.22 $6.3 Million - $14 Million	1,521,800 New	1,521,800 $10.1 Million

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $199M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.